
Journal Menu
► ▼ Journal Menu-
- Biomedicines Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
18 October 2023
Meet Us at Neuroscience 2023, 11–15 November 2023, Washington, DC, USA

Neuroscience 2023 will be held from 11 to 15 November 2023 in Washington, DC, USA. The conference is organized by the Society for Neuroscience.
The conference will gather scientists, clinicians, and decision makers from around the world, creating a platform for the communication of knowledge and the sharing of groundbreaking research on the brain as well as nervous system. As stated in the introduction to the conference, you can “Present new research. Exchange ideas. Expand collaborations. Strengthen your career.”
As one of the exhibitors of Neuroscience 2022 last year, MDPI will be a part of Neuroscience 2023 this year, and looks forward to meeting our scholars as well as new friends, hoping to impress you with our open access publishing model face-to-face.
The following MDPI journals will be represented:
- Brain Sciences.
- JCM.
- Cells.
- NeuroSci.
- J. Intell.
- Neuroglia.
- JPM.
- Biomedicines.
- Clinics and Practice.
- Diagnostics.
- Neurology International.
- Pathophysiology.
- Psych.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.sfn.org/meetings/neuroscience-2023.
13 October 2023
Biomedicines | Hot Papers in the “Neurobiology and Neurologic Disease” Section
Chronic non-communicable neurologic diseases, known to affect the central and the peripheral nervous system, represent the leading cause of disability and the second-leading cause of mortality worldwide. Topics include, but are not limited to, neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics, in vitro and in vivo responses to neurological diseases, identification of therapeutic targets, evaluation of diagnostic markers, and assessment of therapies for neurological disorders.
We invite you to read the following papers:
1. “Dopamine in Health and Disease: Much More Than a Neurotransmitter”
by Rafael Franco, Irene Reyes-Resina and Gemma Navarro
Biomedicines 2021, 9(2), 109; https://doi.org/10.3390/biomedicines9020109
Available online: https://www.mdpi.com/2227-9059/9/2/109
2. “Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions”
by Christian Ogasawara, Brandon D. Philbrick and D. Cory Adamson
Biomedicines 2021, 9(3), 319; https://doi.org/10.3390/biomedicines9030319
Available online: https://www.mdpi.com/2227-9059/9/3/319
3. “The Neurobiological Correlates of Gaze Perception in Healthy Individuals and Neurologic Patients”
by Simone Battaglia, Jasper H. Fabius, Katarina Moravkova, Alessio Fracasso and Sara Borgomaneri
Biomedicines 2022, 10(3), 627; https://doi.org/10.3390/biomedicines10030627
Available online: https://www.mdpi.com/2227-9059/10/3/627
4. “Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling”
by Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, Andras Hajnal and Mihai Covasa
Biomedicines 2022, 10(2), 436; https://doi.org/10.3390/biomedicines10020436
Available online: https://www.mdpi.com/2227-9059/10/2/436
5. “Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection”
by Maria Isabella Donegani, Alberto Miceli, Matteo Pardini, Matteo Bauckneht, Silvia Chiola Michele Pennone, Cecilia Marini, Federico Massa, Stefano Raffa, Giulia Ferrarazzo, Dario Arnaldi et al.
Biomedicines 2021, 9(3), 287; https://doi.org/10.3390/biomedicines9030287
Available online: https://www.mdpi.com/2227-9059/9/3/287
6. “Inflammation, Anxiety, and Stress in Attention-Deficit/Hyperactivity Disorder”
by Luigi F. Saccaro, Zoé Schilliger, Nader Perroud and Camille Piguet
Biomedicines 2021, 9(10), 1313; https://doi.org/10.3390/biomedicines9101313
Available online: https://www.mdpi.com/2227-9059/9/10/1313
7. “Relevance of Autophagy and Mitophagy Dynamics and Markers in Neurodegenerative Diseases”
by Carlotta Giorgi, Esmaa Bouhamida, Alberto Danese, Maurizio Previati, Paolo Pinton and Simone Patergnani
Biomedicines 2021, 9(2), 149; https://doi.org/10.3390/biomedicines9020149
Available online: https://www.mdpi.com/2227-9059/9/2/149
8. “Critical Molecular and Cellular Contributors to Tau Pathology”
by Liqing Song, Evan A. Wells and Anne Skaja Robinson
Biomedicines 2021, 9(2), 190; https://doi.org/10.3390/biomedicines9020190
Available online: https://www.mdpi.com/2227-9059/9/2/190
9. “Mind the Gap: Mitochondria and the Endoplasmic Reticulum in Neurodegenerative Diseases”
by Nuno Santos Leal and Luís Miguel Martins
Biomedicines 2021, 9(2), 227; https://doi.org/10.3390/biomedicines9020227
Available online: https://www.mdpi.com/2227-9059/9/2/227
10. “Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease”
by Victoria García-Morales, Anabel González-Acedo, Lucía Melguizo-Rodríguez, Teresa Pardo-Moreno, Víctor Javier Costela-Ruiz, María Montiel-Troya and Juan José Ramos-Rodríguez
Biomedicines 2021, 9(12), 1910; https://doi.org/10.3390/biomedicines9121910
Available online: https://www.mdpi.com/2227-9059/9/12/1910
We would appreciate it if you could circulate the link of any paper you find appealing within your network.
Submit a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.
Launch a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.
Join the Editorial Board:
We are looking for active scholars who are interested in and passionate about helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).
Biomedicines Editorial Office
2 October 2023
MDPI Insights: The CEO's Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access in China
It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.
Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!
Open Access Policy in China
As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.
Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.
In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.
In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.
MDPI Offices in China
While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.
Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.
In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:
- 2008: Beijing (Tongzhou, Haidian)
- 2013: Wuhan (Hankou, Guanggu)
- 2019: Tianjin
- 2021: Dalian
- 2021: Nanjing
Our Strength is in Our People
With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.
In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.
Impactful Research
MDPI Awards
To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.
In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.
Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.
To learn more about MDPI Awards and to find out which are currently available, please click here.
MDPI Awards to Scholars from China
Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.
MDPI’s Tu Youyou Award
Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).
In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.
The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.
2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu
Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.
Highly Cited Articles by Chinese Scholars Published in MDPI
Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.
Read more:
- Tu Youyou Award
- World Sustainability Awards
- Available Awards
Inside MDPI
Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.
Marketing Department in China
During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.
I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.
Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.
Coming Together for Science
Collaborations, Scholarships and Meetings
MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.
Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.
Scholarships in China
Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).
Meeting with the Society of Chinese University Journals (CUJS)
Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.
I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.
We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.
MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.
Meeting with National Science Library, Chinese Academy of Sciences (NSLC)
Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.
We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.
In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.
The Numbers
As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.
At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.
Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.
Closing Thoughts
Final Reflections on our MDPI Offices in Beijing and Wuhan
Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.
I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.
Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.
95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).
91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.
Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.
Hospitality and Service
Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.
I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.
Chief Executive Officer
MDPI AG
27 September 2023
Biomedicines | Hot Papers in the “Immunology and Immunotherapy” Section
The “Immunology and Immunotherapy” Section of the journal Biomedicines (ISSN: 2227-9059) publishes high-quality reviews and original peer-reviewed papers covering all aspects of immunology and oncoimmunology. The papers published in this Section aim to uncover the modulations of the immune system, active and passive immunotherapies, diagnostic testing based on specific markers and the use of new technologies to identify novel predictive factors to respond to immunotherapy. Topics include, but are not limited to, the following: in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; the use of nanoparticles and microvesicles for developing immunotherapeutics; etc. In this context, we are pleased to feature some recently published papers on immunology and immunotherapy in Biomedicines, which provide valuable insights into this exciting field.
As Biomedicines is an open access journal, the following papers can be read for free:
1. “Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches”
by Luca Fania, Dario Didona, Francesca Romana Di Pietro, Sofia Verkhovskaia, Roberto Morese, Giovanni Paolino, Michele Donati, Francesca Ricci, Valeria Coco, Francesco Ricci et al.
Biomedicines 2021, 9(2), 171; https://doi.org/10.3390/biomedicines9020171
Available online: https://www.mdpi.com/2227-9059/9/2/171
2. “Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography”
by Jorge González-Zamora, Valentina Bilbao-Malavé, Elsa Gándara, Anna Casablanca-Piñera, Claudia Boquera-Ventosa, Manuel F. Landecho, Javier Zarranz-Ventura and Alfredo García-Layana
Biomedicines 2021, 9(3), 247; https://doi.org/10.3390/biomedicines9030247
Available online: https://www.mdpi.com/2227-9059/9/3/247
3. “Relationship between Vitamin D Status and Antibody Response to COVID-19 mRNA Vaccination in Healthy Adults”
by Thilo Samson Chillon, Kamil Demircan, Raban Arved Heller, Ines Maria Hirschbil-Bremer, Joachim Diegmann, Manuel Bachmann, Arash Moghaddam and Lutz Schomburg
Biomedicines 2021, 9(11), 1714; https://doi.org/10.3390/biomedicines9111714
Available online: https://www.mdpi.com/2227-9059/9/11/1714
4. “Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?”
by Kondababu Kurakula, Valérie F. E. D. Smolders, Olga Tura-Ceide, J. Wouter Jukema, Paul H. A. Quax and Marie-José Goumans
Biomedicines 2021, 9(1), 57; https://doi.org/10.3390/biomedicines9010057
Available online: https://www.mdpi.com/2227-9059/9/1/57
5. “Dynamic Changes of the Neutrophil-to-Lymphocyte Ratio, Systemic Inflammation Index, and Derived Neutrophil-to-Lymphocyte Ratio Independently Predict Invasive Mechanical Ventilation Need and Death in Critically Ill COVID-19 Patients”
by Emanuel Moisa, Dan Corneci, Silvius Negoita, Cristina Raluca Filimon, Andreea Serbu, Mihai Ionut Negutu and Ioana Marina Grintescu
Biomedicines 2021, 9(11), 1656; https://doi.org/10.3390/biomedicines9111656
Available online: https://www.mdpi.com/2227-9059/9/11/1656
6. “Roles of XBP1s in Transcriptional Regulation of Target Genes”
by Sung-Min Park, Tae-Il Kang and Jae-Seon So
Biomedicines 2021, 9(7), 791; https://doi.org/10.3390/biomedicines9070791
Available online: https://www.mdpi.com/2227-9059/9/7/791
7. “The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review”
by Claudio Brasso, Silvio Bellino, Cecilia Blua, Paola Bozzatello and Paola Rocca
Biomedicines 2022, 10(4), 772; https://doi.org/10.3390/biomedicines10040772
Available online: https://www.mdpi.com/2227-9059/10/4/772
8. “Role of NLRP7 in Normal and Malignant Trophoblast Cells”
by Roland Abi Nahed, Maya Elkhoury Mikhael, Deborah Reynaud, Constance Collet, Nicolas Lemaitre, Thierry Michy, Pascale Hoffmann, Frederic Sergent, Christel Marquette, Padma Murthi et al.
Biomedicines 2022, 10(2), 252; https://doi.org/10.3390/biomedicines10020252
Available online: https://www.mdpi.com/2227-9059/10/2/252
9. “Puerarin Attenuates Obesity-Induced Inflammation and Dyslipidemia by Regulating Macrophages and TNF-Alpha in Obese Mice”
by Ji-Won Noh, Hee-Kwon Yang, Min-Soo Jun and Byung-Cheol Lee
Biomedicines 2022, 10(1), 175; https://doi.org/10.3390/biomedicines10010175
Available online: https://www.mdpi.com/2227-9059/10/1/175
10. “High Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Are Associated with a Higher Risk of Hemodialysis Vascular Access Failure”
by Edoardo Pasqui, Gianmarco de Donato, Elisa Lazzeri, Cecilia Molino, Giuseppe Galzerano, Michele Giubbolini and Giancarlo Palasciano
Biomedicines 2022, 10(9), 2218; https://doi.org/10.3390/biomedicines10092218
Available online: https://www.mdpi.com/2227-9059/10/9/2218
We would appreciate it if you would share the papers you find interesting with your network.
Submitting a manuscript:
The “Immunology and Immunotherapy” Section is currently open for submissions. Papers may be submitted here.
Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Special Issues can be proposed here.
Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions. Please do not hesitate to get in touch in case you are interested in joining the Editorial Board (biomedicines@mdpi.com).
Biomedicines Editorial Office
25 September 2023
Meet Us at the 2023 Chinese Medicinal Chemistry Symposium & CPA-EFMC International Symposium on Medicinal Chemistry, 7–10 October 2023, Chongqing, China

MDPI will be attending the 2023 Chinese Medicinal Chemistry Symposium & CPA-EFMC International Symposium on Medicinal Chemistry, which will be held from 7 to 10 October 2023 in Chongqing, China.
The conference is held every two years and the theme for 2023 is “Original New Drug Development and New Drug Synthesis Technology”. It aims to promote the deep integration of basic research, new drug R&D, and clinical transformation and improve the overall level of innovative drug R&D and clinical transformation in China. It provides a good exchange and cooperation platform for experts, scholars, and business colleagues in the field of medicinal chemistry and related basic research and clinical transformation.
The following MDPI journals will be represented:
- Molecules;
- Pharmaceuticals;
- Biomedicines;
- Antibiotics.
If you are planning to attend this conference, please feel free to stop by our booth #68 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit the following website: https://www.cmcs2023.com/.
6 September 2023
Recap of Awards Granted to Scholars in 2022

MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.
In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.
The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.
MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:
To explore more MDPI awards, please click here.
5 September 2023
Meet Us at the 16th China Pharmaceutical Preparations Conference, 15–17 September 2023, Changsha, China

The upcoming conference is the 16th so far, and it has become an important conference in the field of pharmaceutical research in China. The theme of this formulation conference is "New Technologies, New Opportunities, and New Challenges" which will be held in Changsha, China. Experts from various fields and directions in pharmacy at home and abroad will be invited to conduct exchanges and discussions on theoretical research, technology applications, policies, and regulations on pharmaceutical formulations. In addition to the main venue, the conference also has a basic pharmacy forum (targeted drug delivery strategy, controlled release strategy), industrial pharmacy forum, International Controlled Release Association China Branch Forum, external preparations forum, improved new drugs and clinical research forum, medicinal excipients and pharmaceutical packaging materials forum, preparation R&D services and equipment forum, young pharmaceutical workers forum, graduate student forum, and other sub-venues.
Pharmaceutics (ISSN: 1999-4923) is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and it is published monthly online by MDPI. Pharmaceutics will participate in this event as an exhibitor together with seven other MDPI journals.
The following MDPI journals will be represented:
- Pharmaceutics (leading);
- Biomedicines;
- Medicina;
- Hematology Reports;
- Polymers;
- Future Pharmacology;
- Pharmacy;
- Bioengineering.
If you are attending this conference, please feel free to start a conversation with us at our booth #A39. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information, please feel free to contact the Pharmaceutics Editorial Office at pharmaceutics@mdpi.com.
5 September 2023
Interview with Prof. Dr. Bernhard Ryffel—Section Board Member of Section “Cell Biology and Pathology” in Biomedicines
We had the pleasure of speaking with Prof. Dr. Bernhard Ryffel, Section Board Member of the “Cell Biology and Pathology” Section in Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and his research interest in the field of immunopharmacology, inflammation and infectious diseases. Prof. Dr. Ryffel is currently research director at CNRS in the laboratory of Molecular Immunology and Embryology in Orleans, France, and Professor and Head of Department of Immunology, University of Cape Town, RSA. We hope you enjoy the interview.
1 September 2023
Meet Us at the Tissue Engineering and Regenerative Medicine International Society (TERMIS–AP) Conference, 16–19 October 2023, Hong Kong, China

MDPI will attend the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AP) conference, which will be held from 16 to 19 October 2023 at the Hong Kong Science Park, Hong Kong, China. The mission of TERMIS–AP is to provide a platform for the generation and dissemination of knowledge and interactions across a range of expertise for the advancement of basic, translational, and clinical research.
The conference will comprise various topics that provide comprehensive coverage of diverse issues in current tissue engineering and regenerative medicine under the main theme of “New Chapter of Future Regenerative Medicine”.
The following MDPI journals will be represented:
If you plan on attending this conference, please feel free to stop by our booth #09 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ap2023.termis.org/.
30 August 2023
MDPI Insights: The CEO's Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Our Commitment to Sustainability
As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.
In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.
MDPI and the Sustainable Development Goals (SDGs)
In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.
“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]
As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:
MDPI journals specializing in sustainability-related topics:
- 2009: Sustainability
- 2012: Resources
- 2013: Climate
- 2014: Environments
- 2016: Recycling
- 2019: Clean Technologies
- 2020: Sustainable Chemistry
- 2021: Wind, Biomass, Conservation, Pollutants, Solar
- 2022: Waste, Microplastics
Read more:
Impactful Research
Highly Cited Articles in Sustainability
In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.
We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.
“Sustainability received a 2022 CiteScore of 5.8”
While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.
Highly Cited Papers in Sustainability
Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.
1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?”Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)
This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.
2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety”Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)
This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.
3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review”Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)
This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.
4. “Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions”Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)
This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.
Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).
Read more:
- Testimonials: See what our editors and authors say about Sustainability.
Inside MDPI
President of Ireland Authors Editorial in MDPI Journal Sustainability
It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:
This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.
The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.
As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.
Read the completed editorial here:
Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683
Coming Together for Science
The World Sustainability Forum 2023
The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.
This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:
- The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
- The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
- The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.
MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research
The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:
- The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
- The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.
The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.
2023 World Sustainability Award Winners
Interviews with 2023 Emerging Sustainability Leader Award Finalists
- Dr. Bahareh Kamranzad
- Dr. Youjin Kim
- Dr. Julia Lohmann
As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.
Read more:
Closing Thoughts
“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier
I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.
MDPI’s Interaction with Elsevier
In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.
“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”
Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.
It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.
‘Fully OA’ Organizations Dedicated to Open Access
MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.
This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.
As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”
Chief Executive Officer
MDPI AG